Carl Zeiss Meditec AG

Carl Zeiss Meditec improves its results in first six months of financial year 2012/2013 - Seite 2

 Outlook - well equipped for further growth

With consistent expansion of our solutions business, based on a broad product range and a balanced regional distribution of business, the Company is sticking firmly to its goals to increase the share of case-number-dependent products and services to 25% by 2015 and to achieve a total EBIT margin of 15%. Steady growth is expected for the current financial year. "We anticipate revenue of between € 880 and 910 million," says Ludwin Monz.

Revenue by strategic business unit

Figures in € '000	6 Months 2011/2012	6 Months 2012/2013	Change from previous year
Ophthalmic Systems	184,781	175,766	-4.9%
Surgical Ophthalmology	51,942	60,459	16.4%
Microsurgery	195,075	206,732	6.0%

Revenue by region

Figures in € '000	6 Months 2011/2012	6 Months 2012/2013	Change from previous year
EMEA	149,423	152,625	2.1%
Americas	144,083	143,875	-0.1%
Asia / Pacific region	138,292	146,457	5.9%

Press contacts:

Jann Gerrit Ohlendorf, Corporate Communications, Carl Zeiss Meditec AG
Phone[phone], E-Mail: [e-mail]

Contact for investors:
Henriette Meyer, Investor Relations, Carl Zeiss Meditec AG
Phone [phone], E-Mail: [e-mail]

www.meditec.zeiss.com/press

Carl Zeiss Meditec AG
Carl Zeiss Meditec AG (ISIN: DE 0005313704), which is listed on TecDAX of the German stock exchange, is one of the world's leading medical technology companies. The company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. It provides complete packages of solutions for the diagnosis and treatment of eye diseases, including implants and consumable materials. The company creates innovative visualization solutions in the field of microsurgery. The medical technology portfolio of Carl Zeiss Meditec is rounded off by promising, future-oriented technologies such as intraoperative radiotherapy. In financial year 2011/2012 (ended 30 September) the Group's more than 2,400 employees generated revenue of almost € 862 million. The head office of Carl Zeiss Meditec is in Jena, Germany.